======= ZFYVE19 =======
== Gene Information ==
* **Official Symbol**: ZFYVE19
* **Official Name**: zinc finger FYVE-type containing 19
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84936|84936]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96K21|Q96K21]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ZFYVE19&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZFYVE19|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/619635|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Key regulator of abscission step in cytokinesis: part of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage. Together with CHMP4C, required to retain abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis. Deactivation of AURKB results in dephosphorylation of CHMP4C followed by its dissociation from ZFYVE19/ANCHR and VPS4 and subsequent abscission. {ECO:0000269|PubMed:24814515}.
|FYVE|
|mitotic cytokinesis checkpoint|
|abscission|
|negative regulation of cytokinesis|
|negative regulation of cell division|
|Flemming body|
|phosphatidylinositol-3-phosphate binding|
|cleavage furrow|
|negative regulation of G2/M transition of mitotic cell cycle|
|regulation of cytokinesis|
|negative regulation of cell cycle G2/M phase transition|
|mitotic cell cycle checkpoint|
|midbody|
|regulation of cell division|
|cell cycle checkpoint|
|regulation of G2/M transition of mitotic cell cycle|
|regulation of cell cycle G2/M phase transition|
|negative regulation of mitotic cell cycle phase transition|
|negative regulation of cell cycle phase transition|
|negative regulation of mitotic cell cycle|
|negative regulation of cell cycle process|
|regulation of mitotic cell cycle phase transition|
|regulation of cell cycle phase transition|
|centrosome|
|cell division|
|negative regulation of cell cycle|
|mitotic cell cycle process|
|regulation of mitotic cell cycle|
|mitotic cell cycle|
|regulation of cell cycle process|
|cell cycle process|
|regulation of cell cycle|
|cell cycle|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-1.86|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4380
* **Expression level (log2 read counts)**: 5.08
{{:chemogenomics:nalm6 dist.png?nolink |}}